Blueberries: from superfood to a potential PTSD treatment
Could blueberries be used to relieve the symptoms of post-traumatic stress disorder (PTSD)? While this is far from an obvious…
All articles by Taylor Heyman
Taylor Heyman
-
-
Benign by design: the long road to biodegradable drugs
For decades pharmaceuticals have been designed to be as stable as possible, so by the time they reach their eventual…
-
A new pharmaceutical hope for heroin addiction?
For researchers working in the field of public health and addiction, long-term opiate users pose a conundrum. While most users…
-
Durbin CEO Leslie Morgan talks saving lives through the supply chain
A 40-year veteran of the pharmaceutical industry, there are few who have more experience of the medical supply chain than…
-
Olive leaf extract: on trial
Olive oil has long captured the popular imagination as the bedrock of a healthy diet. Used liberally in the Mediterranean…
-
Russia: a bright future for clinical trials?
Russia has been boosting its credentials as a location for international clinical trials, with 70% of new drugs registered in…
-
Pregnancy and childbirth: where are the new drugs?
Pregnancy and childbirth have become much safer in many countries over the last few decades. According to the World Health…
-
Sick, dying and on a placebo: could we do away with it altogether?
Concern about receiving the placebo is one of the biggest barriers to clinical trial recruitment. It's just one factor that…